| Molecular and therapeutic potential and toxicity of valproic acid S Chateauvieux, F Morceau, M Dicato, M Diederich BioMed Research International 2010 (1), 479364, 2010 | 639 | 2010 |
| Erythropoietin, erythropoiesis and beyond S Chateauvieux, C Grigorakaki, F Morceau, M Dicato, M Diederich Biochemical pharmacology 82 (10), 1291-1303, 2011 | 243 | 2011 |
| The concept of mesenchymal stem cells B Delorme, S Chateauvieux, P Charbord Regenerative medicine 1 (4), 497-509, 2006 | 182 | 2006 |
| Reply to: Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib E Maiani, C Di Bartolomeo, FG Klinger, SM Cannata, S Bernardini, ... Nature medicine 18 (8), 1172-1174, 2012 | 129 | 2012 |
| Selective modulation of the glucocorticoid receptor can distinguish between transrepression of NF-κB and AP-1 K De Bosscher, IM Beck, L Dejager, N Bougarne, A Gaigneaux, ... Cellular and Molecular life sciences 71, 143-163, 2014 | 107 | 2014 |
| Heteronemin, a spongean sesterterpene, inhibits TNFα-induced NF-κB activation through proteasome inhibition and induces apoptotic cell death M Schumacher, C Cerella, S Eifes, S Chateauvieux, F Morceau, ... Biochemical Pharmacology 79 (4), 610-622, 2010 | 106 | 2010 |
| Tumor necrosis factor α inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 … I Buck, F Morceau, S Cristofanon, C Heintz, S Chateauvieux, S Reuter, ... biochemical pharmacology 76 (10), 1229-1239, 2008 | 87 | 2008 |
| Long and short non-coding RNAs as regulators of hematopoietic differentiation F Morceau, S Chateauvieux, A Gaigneaux, M Dicato, M Diederich International journal of molecular sciences 14 (7), 14744-14770, 2013 | 86 | 2013 |
| Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells M Orsini, S Chateauvieux, J Rhim, A Gaigneaux, D Cheillan, C Christov, ... Cell Death & Differentiation 26 (9), 1796-1812, 2019 | 82 | 2019 |
| Tumor necrosis factor alpha-mediated inhibition of erythropoiesis involves GATA-1/GATA-2 balance impairment and PU. 1 over-expression C Grigorakaki, F Morceau, S Chateauvieux, M Dicato, M Diederich Biochemical pharmacology 82 (2), 156-166, 2011 | 72 | 2011 |
| Eurycomanone and Eurycomanol from Eurycoma longifolia Jack as Regulators of Signaling Pathways Involved in Proliferation, Cell Death and Inflammation S Hajjouli, S Chateauvieux, MH Teiten, B Orlikova, M Schumacher, ... Molecules 19 (9), 14649-14666, 2014 | 68 | 2014 |
| Early downregulation of Mcl-1 regulates apoptosis triggered by cardiac glycoside UNBS1450 C Cerella, F Muller, A Gaigneaux, F Radogna, E Viry, S Chateauvieux, ... Cell death & disease 6 (6), e1782-e1782, 2015 | 61 | 2015 |
| Molecular profile of mouse stromal mesenchymal stem cells S Chateauvieux, JL Ichanté, B Delorme, V Frouin, G Piétu, A Langonné, ... Physiological Genomics 29 (2), 128-138, 2007 | 59 | 2007 |
| Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation C Spagnuolo, C Cerella, M Russo, S Chateauvieux, M Diederich, ... British journal of cancer 105 (2), 221-230, 2011 | 56 | 2011 |
| Identification of differentially expressed proteins in curcumin-treated prostate cancer cell lines MH Teiten, A Gaigneaux, S Chateauvieux, AM Billing, S Planchon, F Fack, ... Omics: a journal of integrative biology 16 (6), 289-300, 2012 | 50 | 2012 |
| Distinct osteoblastic differentiation potential of murine fetal liver and bone marrow stroma‐derived mesenchymal stem cells O Fromigué, Z Hamidouche, S Chateauvieux, P Charbord, PJ Marie Journal of cellular biochemistry 104 (2), 620-628, 2008 | 48 | 2008 |
| Valproic acid perturbs hematopoietic homeostasis by inhibition of erythroid differentiation and activation of the myelo-monocytic pathway S Chateauvieux, S Eifes, F Morceau, C Grigorakaki, M Schnekenburger, ... Biochemical pharmacology 81 (4), 498-509, 2011 | 46 | 2011 |
| Natural compounds and pharmaceuticals reprogram leukemia cell differentiation pathways F Morceau, S Chateauvieux, M Orsini, A Trécul, M Dicato, M Diederich Biotechnology advances 33 (6), 785-797, 2015 | 42 | 2015 |
| Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP release A Mazumder, JY Lee, O Talhi, C Cerella, S Chateauvieux, A Gaigneaux, ... Cancer letters 438, 197-218, 2018 | 33 | 2018 |
| 2, 5-Dimethyl-celecoxib inhibits cell cycle progression and induces apoptosis in human leukemia cells C Sobolewski, J Rhim, N Legrand, F Muller, C Cerella, F Mack, ... The Journal of Pharmacology and Experimental Therapeutics 355 (2), 308-328, 2015 | 33 | 2015 |
Marc DiederichCollege of Pharmacy, Seoul National University, South Korea; formerly: LBMCC, LuxembourgZweryfikowany adres z snu.ac.kr